Table 1 Patient demographics, clinical characteristics, analgesic requirements, and NV scores
Group K (n: 23) | Group B (n: 23) | p-value | |
|---|---|---|---|
Age (years) | 65.17 ± 4.9 | 66.35 ± 6.7 | 0.122 |
Weight (kg) | 82.39 ± 14.7 | 79.82 ± 9.6 | 0.072 |
Height (cm) | 176.09 ± 8.1 | 174.22 ± 7.7 | 0.858 |
ASA (I, II) | 2 (%8.7), 21 (%91.3) | 5 (%21.7), 18 (%78.3) | 0.094 |
Anesthesia time (min) | 142.39 ± 36.1 | 164.56 ± 37.9 | 0.666 |
Surgery time (min) | 120.43 ± 28.6 | 135.65 ± 31.5 | 0.383 |
Remifentanyl consumption rate (µg/kg/min) | 0.0812 ± 0.037 | 0.0233 ± 0.020 | 0.028 |
Tramadol consumption (mg) | 442.17 ± 64.0 | 208.70 ± 88.9 | < 0.001 |
PONV scores | 1.26 ± 0.8 | 1.17 ± 0.8 | 0.671 |